ÂÜÀòÂÒÂ×

Dr. Menon-Rudolph was installed on the Board in February, 2022. Dr. Menon-Rudolph's term will expire June 30, 2027.

Sunitha Menon-Rudolph earned her bachelor’s degree in chemistry from the Women’s Christian College (University of Madras), India in 1981. She later received her Ph.D. in Biochemistry from Bryn Mawr College in 1987 and held two post-doctoral fellowships with Temple University and Rutgers University prior to joining the Pharmaceutical Industry. She is a certified Project Management Professional. Currently, Dr. Menon-Rudolph continues to remain engaged in pharmaceuticals and drug development as an Independent Consultant.